OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial
Antoni Ribas, Jeffrey S. Weber, Bartosz Chmielowski, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 9, pp. 2987-2996
Open Access | Times Cited: 70
Antoni Ribas, Jeffrey S. Weber, Bartosz Chmielowski, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 9, pp. 2987-2996
Open Access | Times Cited: 70
Showing 1-25 of 70 citing articles:
Therapeutic cancer vaccines: past, present, and future.
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, et al.
Europe PMC (PubMed Central) (2013) Vol. 119, pp. 421-75
Open Access | Times Cited: 559
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, et al.
Europe PMC (PubMed Central) (2013) Vol. 119, pp. 421-75
Open Access | Times Cited: 559
Material design for lymph node drug delivery
Alex Schudel, David M. Francis, Susan N. Thomas
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 415-428
Open Access | Times Cited: 384
Alex Schudel, David M. Francis, Susan N. Thomas
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 415-428
Open Access | Times Cited: 384
Non-viral COVID-19 vaccine delivery systems
Kyong Soo Park, Xiaoqi Sun, Marisa Aikins, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 137-151
Open Access | Times Cited: 201
Kyong Soo Park, Xiaoqi Sun, Marisa Aikins, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 137-151
Open Access | Times Cited: 201
Nano‐particle vaccination combined with TLR ‐7 and ‐9 ligands triggers memory and effector CD 8+T ‐cell responses in melanoma patients
Simone M. Goldinger, Reinhard Dummer, Petra Baumgaertner, et al.
European Journal of Immunology (2012) Vol. 42, Iss. 11, pp. 3049-3061
Open Access | Times Cited: 185
Simone M. Goldinger, Reinhard Dummer, Petra Baumgaertner, et al.
European Journal of Immunology (2012) Vol. 42, Iss. 11, pp. 3049-3061
Open Access | Times Cited: 185
Trial watch
Erika Vacchelli, Isabelle Martins, Alexander Eggermont, et al.
OncoImmunology (2012) Vol. 1, Iss. 9, pp. 1557-1576
Open Access | Times Cited: 169
Erika Vacchelli, Isabelle Martins, Alexander Eggermont, et al.
OncoImmunology (2012) Vol. 1, Iss. 9, pp. 1557-1576
Open Access | Times Cited: 169
Antigen-specific vaccines for cancer treatment
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3332-3346
Open Access | Times Cited: 145
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3332-3346
Open Access | Times Cited: 145
Cancer immunotherapies, their safety and toxicity
Gheath Alatrash, Haroon Jakher, Patricia Stafford, et al.
Expert Opinion on Drug Safety (2013) Vol. 12, Iss. 5, pp. 631-645
Closed Access | Times Cited: 137
Gheath Alatrash, Haroon Jakher, Patricia Stafford, et al.
Expert Opinion on Drug Safety (2013) Vol. 12, Iss. 5, pp. 631-645
Closed Access | Times Cited: 137
Tumour Immunogenicity, Antigen Presentation, and Immunological Barriers in Cancer Immunotherapy
David Escors
New Journal of Science (2014) Vol. 2014, pp. 1-25
Open Access | Times Cited: 107
David Escors
New Journal of Science (2014) Vol. 2014, pp. 1-25
Open Access | Times Cited: 107
Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies
Antonio Di Stasi, Antonio Jiménez, Kentaro Minagawa, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 94
Antonio Di Stasi, Antonio Jiménez, Kentaro Minagawa, et al.
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 94
Therapeutic cancer vaccines: From initial findings to prospects
Qian Song, Cheng-dong Zhang, Xianghua Wu
Immunology Letters (2018) Vol. 196, pp. 11-21
Closed Access | Times Cited: 93
Qian Song, Cheng-dong Zhang, Xianghua Wu
Immunology Letters (2018) Vol. 196, pp. 11-21
Closed Access | Times Cited: 93
Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering
Jie Wang, Zongying Zhang, Rongxiang Liang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101068-101068
Open Access | Times Cited: 8
Jie Wang, Zongying Zhang, Rongxiang Liang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101068-101068
Open Access | Times Cited: 8
Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
James I. Andorko, Krystina L. Hess, Christopher M. Jewell
The AAPS Journal (2014) Vol. 17, Iss. 2, pp. 323-338
Open Access | Times Cited: 83
James I. Andorko, Krystina L. Hess, Christopher M. Jewell
The AAPS Journal (2014) Vol. 17, Iss. 2, pp. 323-338
Open Access | Times Cited: 83
A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors
Jeffrey S. Weber, Nicholas J. Vogelzang, Marc S. Ernstoff, et al.
Journal of Immunotherapy (2011) Vol. 34, Iss. 7, pp. 556-567
Open Access | Times Cited: 82
Jeffrey S. Weber, Nicholas J. Vogelzang, Marc S. Ernstoff, et al.
Journal of Immunotherapy (2011) Vol. 34, Iss. 7, pp. 556-567
Open Access | Times Cited: 82
Multifaceted Immunomodulatory Nanoliposomes: Reshaping Tumors into Vaccines for Enhanced Cancer Immunotherapy
Young‐Woock Noh, Sunyoung Kim, Jung‐Eun Kim, et al.
Advanced Functional Materials (2017) Vol. 27, Iss. 8
Closed Access | Times Cited: 73
Young‐Woock Noh, Sunyoung Kim, Jung‐Eun Kim, et al.
Advanced Functional Materials (2017) Vol. 27, Iss. 8
Closed Access | Times Cited: 73
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
Carole Fournier, François Martin, Laurence Zitvogel, et al.
OncoImmunology (2017) Vol. 6, Iss. 11, pp. e1363139-e1363139
Open Access | Times Cited: 67
Carole Fournier, François Martin, Laurence Zitvogel, et al.
OncoImmunology (2017) Vol. 6, Iss. 11, pp. e1363139-e1363139
Open Access | Times Cited: 67
Engineering Immune Tolerance with Biomaterials
Joshua M. Gammon, Christopher M. Jewell
Advanced Healthcare Materials (2019) Vol. 8, Iss. 4
Open Access | Times Cited: 64
Joshua M. Gammon, Christopher M. Jewell
Advanced Healthcare Materials (2019) Vol. 8, Iss. 4
Open Access | Times Cited: 64
Cell and tissue engineering in lymph nodes for cancer immunotherapy
Alexander J. Najibi, David Mooney
Advanced Drug Delivery Reviews (2020) Vol. 161-162, pp. 42-62
Open Access | Times Cited: 59
Alexander J. Najibi, David Mooney
Advanced Drug Delivery Reviews (2020) Vol. 161-162, pp. 42-62
Open Access | Times Cited: 59
T‐cell subsets in the skin and their role in inflammatory skin disorders
Inge Kortekaas Krohn, Joeri L. Aerts, Karine Breckpot, et al.
Allergy (2021) Vol. 77, Iss. 3, pp. 827-842
Open Access | Times Cited: 55
Inge Kortekaas Krohn, Joeri L. Aerts, Karine Breckpot, et al.
Allergy (2021) Vol. 77, Iss. 3, pp. 827-842
Open Access | Times Cited: 55
Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation
Joshua M. Gammon, Sean T. Carey, Vikas Saxena, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Joshua M. Gammon, Sean T. Carey, Vikas Saxena, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis
María Contador-Troca, Alberto Álvarez, Eva Barrasa, et al.
Carcinogenesis (2013) Vol. 34, Iss. 12, pp. 2683-2693
Open Access | Times Cited: 69
María Contador-Troca, Alberto Álvarez, Eva Barrasa, et al.
Carcinogenesis (2013) Vol. 34, Iss. 12, pp. 2683-2693
Open Access | Times Cited: 69
Genetic cancer vaccines: current status and perspectives
Luigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Biological Therapy (2012) Vol. 12, Iss. 8, pp. 1043-1058
Closed Access | Times Cited: 65
Luigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Biological Therapy (2012) Vol. 12, Iss. 8, pp. 1043-1058
Closed Access | Times Cited: 65
Lymph nodes: at the intersection of cancer treatment and progression
Nathan E. Reticker-Flynn, Edgar G. Engleman
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1021-1034
Open Access | Times Cited: 16
Nathan E. Reticker-Flynn, Edgar G. Engleman
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1021-1034
Open Access | Times Cited: 16
Intralymphatic immunotherapy
Gabriela Senti, Thomas M. Kündig
World Allergy Organization Journal (2015) Vol. 8, pp. 9-9
Open Access | Times Cited: 43
Gabriela Senti, Thomas M. Kündig
World Allergy Organization Journal (2015) Vol. 8, pp. 9-9
Open Access | Times Cited: 43
Intra-lymph Node Injection of Biodegradable Polymer Particles
James I. Andorko, Lisa H. Tostanoski, Eduardo Solano, et al.
Journal of Visualized Experiments (2014), Iss. 83
Open Access | Times Cited: 42
James I. Andorko, Lisa H. Tostanoski, Eduardo Solano, et al.
Journal of Visualized Experiments (2014), Iss. 83
Open Access | Times Cited: 42
Strategies in DNA vaccine for melanoma cancer
Tayebeh Rezaei, Elham Davoudian, Saeed Khalili, et al.
Pigment Cell & Melanoma Research (2020) Vol. 34, Iss. 5, pp. 869-891
Open Access | Times Cited: 38
Tayebeh Rezaei, Elham Davoudian, Saeed Khalili, et al.
Pigment Cell & Melanoma Research (2020) Vol. 34, Iss. 5, pp. 869-891
Open Access | Times Cited: 38
